Blinatumomab

5 registered clinical trials studyying Blinatumomab — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Resid NCT07192237	M.D. Anderson Cancer Center	Phase 2
Not Yet Recruiting	Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphi NCT07178912	M.D. Anderson Cancer Center	Phase 2
Not Yet Recruiting	A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged NCT07283640	M.D. Anderson Cancer Center	Phase 1
Recruiting	Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy NCT06985485	The First Affiliated Hospital of Soochow University	Phase 2
Recruiting	Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus NCT06789107	Mao Jianhua	Phase 1